Standard BioTools Inc. Common Stock — Grafico, Quotazione e Notizie (NASDAQ:LAB)

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 343.26 M
Employee 389
Founded 1999
CEO N/A
Website www.standardbio.com
Headquarter Delaware, United States
FIGI BBG000S8WQB6
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

343.26 M Capitalizzazione di mercato

Rapporto prezzo/utili

-6.4

Rapporto prezzo/fatturato

5.73

Standard BioTools Inc

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.